Literature DB >> 884387

Plasma nortriptyline and cardiac responses in young and old rats.

A Bonaccorsi, R Franco, S Garattini, P L Morselli, E Pita.   

Abstract

1. The relationship between plasma concentrations and cardiac effects of nortriptyline was studied in anaesthetized young and old rats. 2. Nortriptyline was administered by two consecutive intravenous infusions which resulted in a peak plasma concentration followed by steady state values. Increasing infusion rates were followed by proportional increases in the drug plasma concentrations ranging from 0.15 to 6.0 microgram/ml. 3. In young rats, nortriptyline induced an increase in the heart rate, a right rotation of the electrical axis and a prolongation of the PQ interval. Heart rate changes were not correlated with nortriptyline plasma concentrations, while significant correlations were found for the other two parameters. Plasma concentrations inducing 20% increase of the PQ interval and 40 degrees rotation of the electrical axis were 1.65 microgram/ml respectively. Arrhythmias occurred at concentrations higher than 5.2 microgram/ml. 4. Nortriptyline caused more severe cardiac effects in old than in young animals. However, plasma concentrations of nortriptyline in old rats were two to five times higher than those found in young rats at similar infusion rates. A higher concentration of the drug at its sites of action seems to be responsible for the more severe cardiac toxicity of nortriptyline observed in old rats.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 884387      PMCID: PMC1667182          DOI: 10.1111/j.1476-5381.1977.tb16742.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  A pharmacological basis for the cardiovascular complications of imipramine medication.

Authors:  K D CAIRNCROSS; S GERSHON
Journal:  Med J Aust       Date:  1962-09-08       Impact factor: 7.738

2.  The hypotensive effect of imipramine hydrocloride in patients with cardiovascular disease.

Authors:  O F MULLER; N GOODMAN; S BELLET
Journal:  Clin Pharmacol Ther       Date:  1961 May-Jun       Impact factor: 6.875

3.  Plasma concentrations and cardiotoxic effects of desipramine and protriptyline in the rat.

Authors:  G Bianchetti; A Bonaccorsi; A Chiodaroli; R Franco; S Garattini; R Gomeni; P L Morselli
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

4.  Plasma nortriptyline and clinical response.

Authors:  G Burrows; B A Scoggins; L R Turecek; B Davies
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

5.  Plasma nortriptyline levels--relationship to clinical effects.

Authors:  M Asberg
Journal:  Clin Pharmacol Ther       Date:  1974-07       Impact factor: 6.875

6.  A safe method for rapidly achieving plasma concentration plateaus.

Authors:  J G Wagner
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

7.  The effects of the tricyclic antidepressants desipramine, doxepin and iprindole on the isolated perfused rabbit heart.

Authors:  N Barth; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

8.  Cardiovascular abnormalities following tricyclic antidepressant drug overdosage.

Authors:  J K Vohra
Journal:  Drugs       Date:  1974       Impact factor: 9.546

9.  Metabolism of drugs in old rats. II. Metabolism in vivo and effect of drugs in old rats.

Authors:  R Kato; A Takanaka
Journal:  Jpn J Pharmacol       Date:  1968-12

10.  [Pharmacokinetics of dimeylaminophenazone, 4-aminophenazone and phenazone in rats of various ages].

Authors:  W Klinger
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-08
View more
  1 in total

1.  Influence of the rate of intravenous administration of eliprodil (SL 82.0715), a new anti-ischaemic agent, on its distribution in rat plasma and tissues.

Authors:  D Garrigou-Gadenne; J P Thenot; P L Morselli
Journal:  J Pharmacokinet Biopharm       Date:  1995-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.